Matches in Nanopublications for { ?s ?p "[On the basis of our data showing that melanoma iNOS expression predicts shortened patient survival, we formulated the hypothesis that activating mutations of NRAS or BRAF, which lead to constitutive activation of the p44/42 MAPK pathway, drive iNOS expression in human melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP157630.RAUpmkztIJ3f4NxkP58dCEK4qfym59WMS-D_8D9eD9r0w130_assertion description "[On the basis of our data showing that melanoma iNOS expression predicts shortened patient survival, we formulated the hypothesis that activating mutations of NRAS or BRAF, which lead to constitutive activation of the p44/42 MAPK pathway, drive iNOS expression in human melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP157630.RAUpmkztIJ3f4NxkP58dCEK4qfym59WMS-D_8D9eD9r0w130_provenance.
- NP785780.RAzUlr_aXEdWMj4HXZp-9z08CMo_APeuw2deu1jcrUse0130_assertion description "[On the basis of our data showing that melanoma iNOS expression predicts shortened patient survival, we formulated the hypothesis that activating mutations of NRAS or BRAF, which lead to constitutive activation of the p44/42 MAPK pathway, drive iNOS expression in human melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP785780.RAzUlr_aXEdWMj4HXZp-9z08CMo_APeuw2deu1jcrUse0130_provenance.
- NP293186.RAOkQkKgAH-H5CpiMxuvZFUHuGenHGryKqC9Cfeg0_j_Q130_assertion description "[On the basis of our data showing that melanoma iNOS expression predicts shortened patient survival, we formulated the hypothesis that activating mutations of NRAS or BRAF, which lead to constitutive activation of the p44/42 MAPK pathway, drive iNOS expression in human melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP293186.RAOkQkKgAH-H5CpiMxuvZFUHuGenHGryKqC9Cfeg0_j_Q130_provenance.
- NP535632.RAAHSqLuf7T9tpluQJPPgjU1Ps82Xu2z7OFYmEVT9yHzw130_assertion description "[On the basis of our data showing that melanoma iNOS expression predicts shortened patient survival, we formulated the hypothesis that activating mutations of NRAS or BRAF, which lead to constitutive activation of the p44/42 MAPK pathway, drive iNOS expression in human melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535632.RAAHSqLuf7T9tpluQJPPgjU1Ps82Xu2z7OFYmEVT9yHzw130_provenance.
- NP535633.RAcgXdR8IQrigfX92qAPEsVEJgff38Vm6pGH_7TYXhSmo130_assertion description "[On the basis of our data showing that melanoma iNOS expression predicts shortened patient survival, we formulated the hypothesis that activating mutations of NRAS or BRAF, which lead to constitutive activation of the p44/42 MAPK pathway, drive iNOS expression in human melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535633.RAcgXdR8IQrigfX92qAPEsVEJgff38Vm6pGH_7TYXhSmo130_provenance.
- assertion description "[On the basis of our data showing that melanoma iNOS expression predicts shortened patient survival, we formulated the hypothesis that activating mutations of NRAS or BRAF, which lead to constitutive activation of the p44/42 MAPK pathway, drive iNOS expression in human melanoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.